South Africa ordered to disclose contracts with Covid vaccine suppliers; court strikes down key parts of PBM law

Taking stock of the drug industry, from the lab to the medicine chest

August 17, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Jon Cherry/Getty Images STAT+ | South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers "This is a victory for democracy," said Fatima Hassan, who founded Health Justice Initiative, an advocacy group that sued the government. By Ed Silverman STAT+ | U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers. By Ed Silverman STAT+ | Blue Shield of California overhauls drug pricing operation — by adding more vendors Blue Shield of California is restructuring how it will pay for prescription drugs by dividing the work up among five different vendors. By Bob Herman ActiGraph STAT+ | ActiGraph executives on why getting digital endpoints approved for drug trials matters ActiGraph executives spoke with STAT about getting a drug approved with a digital endpoint in a clinical trial using wearables. By Mario Aguilar STAT+ | Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows The CEOs of more than 300 publicly traded health care companies combined to make $4 billion in 2022, according to a STAT analysis. By Bob Herman and J. Emory Parker and Adam Feuerstein and Lizzy Lawrence and Mohana Ravindranath

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser